1. Introduction

Digital Twin Healthcare Law is an emerging area of healthcare, medical technology, data protection, artificial intelligence and medical liability law. It deals with the legal regulation of digital replicas of human beings, organs, tissues, diseases or physiological systems that are used for medical diagnosis, treatment planning, clinical research and health monitoring.

A digital twin is a computer-generated virtual representation of a real-world patient or biological system. It uses information such as:

Electronic health records.

Medical imaging, including MRI, CT and ultrasound.

Genetic and genomic information.

Heart rate, blood pressure and other physiological measurements.

Wearable-device and sensor information.

Artificial intelligence and machine-learning predictions.

Real-time clinical and laboratory data.

For example, a hospital may create a digital model of a patient's heart to simulate how different treatments, medications or surgical procedures could affect that patient's cardiovascular system.

Digital twins can improve precision medicine, reduce unnecessary procedures and support personalised treatment. However, they also create significant legal questions concerning patient consent, privacy, cybersecurity, medical negligence, algorithmic discrimination, intellectual property and accountability when a digital prediction causes physical harm.

Important legal distinction: There is not yet a universally recognised, comprehensive legal framework specifically governing healthcare digital twins. Their regulation generally operates through existing medical-device, privacy, AI, consumer-protection, professional-negligence and research laws.

2. Meaning and Types of Healthcare Digital Twins

Spatial and Synthetic Data Power Healthcare Digital Twins

Digital twins: Any human heart - TechInformed

Patient Digital Twin พลิกโฉมการดูแลผู้ป่วย สู่ Smart Ward อย่างแท้จริง

12

The principal categories include:

Patient digital twins: Virtual representations of an individual patient's overall health condition.

Organ digital twins: Digital models of the heart, brain, lungs, kidneys or other organs.

Disease digital twins: Simulations of cancer progression, cardiovascular disorders or other diseases.

Surgical digital twins: Models used to plan and simulate surgical procedures.

Pharmaceutical digital twins: Models used to predict how an individual patient may respond to particular medicines.

Hospital digital twins: Virtual representations of hospital infrastructure, equipment, patient flows and healthcare operations.

The legal obligations may differ according to whether a digital twin is used for clinical decision-making, research, administrative management or commercial product development.

3. Legal Framework Governing Digital Twin Healthcare in India

India does not currently have a standalone Digital Twin Healthcare Act. Several existing legal frameworks may apply.

A. Constitution of India

Article 21 – Right to Life and Personal Liberty

The right to life has been interpreted to include important dimensions of privacy, dignity and personal autonomy.

Digital twins may process extremely sensitive medical information, including genetic characteristics, reproductive information and disease predictions.

Healthcare institutions must therefore respect patient autonomy, confidentiality and privacy.

Article 14 – Equality Before Law

If digital twin algorithms produce discriminatory treatment recommendations based on sex, disability, socioeconomic circumstances or other protected characteristics, constitutional equality principles may become relevant, particularly where public authorities or state-controlled healthcare institutions are involved.

B. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 is relevant to the processing of digital patient information within its scope.

Important compliance issues include:

Lawful processing of personal data.

Notice and consent requirements, where applicable.

Security safeguards.

Obligations of data fiduciaries.

Data-principal rights.

Breach-related obligations.

Restrictions and conditions relating to children's personal data.

Digital twins may combine several datasets into a highly detailed profile of an identifiable patient.

Consequently, healthcare organisations must consider whether their collection, use, storage, sharing and secondary research activities comply with applicable data-protection requirements.

C. Information Technology Act, 2000

The IT Act may apply to cybersecurity incidents, unauthorised access and certain forms of misuse of digital health information.

Section 43 addresses specified unauthorised computer-related activities, while Section 66 addresses certain acts under Section 43 when committed dishonestly or fraudulently.

D. Medical Device Rules, 2017

Software intended for medical purposes may fall within the medical-device regulatory framework depending on its intended purpose, functionality and classification.

A digital twin used to support diagnosis, predict clinical outcomes or guide treatment may therefore require regulatory assessment under the applicable medical-device rules.

E. Consumer Protection Act, 2019

If a healthcare digital twin product or service is defective, misleadingly marketed or negligently supplied, consumer-protection issues may arise.

Patients may potentially seek remedies for deficient services, unfair trade practices or product-related defects, depending on the circumstances.

F. Digital Health and Medical Ethics Guidelines

The following frameworks are also relevant:

Telemedicine Practice Guidelines, 2020: Relevant when digital twins support remote consultations and clinical decision-making.

ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017: Relevant to research involving patient-derived data and experimental digital models.

National Digital Health Mission / Ayushman Bharat Digital Mission framework: Relevant to health-data exchange, interoperability and digital health infrastructure.

4. Data Privacy and Patient Consent

Privacy is one of the most important legal challenges in digital twin healthcare.

A patient's digital twin may reveal information that the patient has never directly disclosed, including:

Predicted genetic disorders.

Potential future diseases.

Reproductive health characteristics.

Mental health risks.

Drug-response probabilities.

Familial and inherited medical characteristics.

Legal questions

1. Is consent required to create a digital twin?

Where personal health data is processed, the applicable legal basis and consent requirements must be examined. Consent for ordinary treatment should not automatically be treated as consent for every secondary use, such as commercial AI development or pharmaceutical research.

2. Can a hospital share digital twin information with technology companies?

Such sharing must have a lawful basis and comply with applicable privacy, confidentiality and contractual obligations.

3. Can a patient request deletion of a digital twin?

This depends on applicable data-protection rights, retention requirements, medical-record obligations and other lawful grounds for retaining information.

4. Can a digital twin be used without the patient's knowledge?

Unlawful or undisclosed processing may raise privacy, confidentiality and consent issues.

Important case law

Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

Supreme Court of India

The Supreme Court recognised privacy as a fundamental right under Article 21 and Part III of the Constitution.

The judgment recognised informational privacy and individual autonomy.

Application to digital twins: Healthcare organisations should protect the confidentiality of patient information and ensure that the use of highly detailed digital health profiles respects constitutional privacy principles.

Sci API

5. Medical Negligence and Digital Twin Liability

One of the most difficult legal questions is determining who is responsible when a digital twin produces an incorrect medical prediction.

Consider this example:

A hospital develops a digital twin of a patient's heart. The system predicts that the patient has a low risk of cardiac complications. The doctor relies heavily on that prediction and delays an important procedure. The patient subsequently suffers a heart attack.

Potentially responsible parties may include:

The treating doctor.

The hospital.

The digital twin software developer.

The medical-device manufacturer.

The data provider.

The institution responsible for validating the model.

Liability depends on the facts, contractual relationships, applicable legislation, causation and the respective duties of each party.

Important case laws

A. Jacob Mathew v. State of Punjab (2005) 6 SCC 1

Supreme Court of India

The Supreme Court explained the principles governing medical negligence and the standard of professional care.

The judgment established that a medical professional is not automatically negligent merely because treatment fails. The conduct must be assessed against the standard of a reasonably competent professional.

Application: A doctor using a digital twin must exercise reasonable professional judgment. Blind reliance on an unreliable prediction may constitute negligence if it falls below the applicable standard of care.

Sci API

B. Kusum Sharma v. Batra Hospital & Medical Research Centre (2010) 3 SCC 480

The Supreme Court discussed the principles used to determine medical negligence, including the requirement to assess professional conduct in its particular circumstances.

Application: Courts may need expert evidence to determine whether the doctor reasonably relied on the digital twin, whether the software was sufficiently validated and whether alternative diagnostic measures should have been undertaken.

Sci API

C. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

The Supreme Court emphasised the importance of valid patient consent before medical intervention.

Application: A patient agreeing to conventional medical treatment does not necessarily mean that the patient has agreed to every additional intervention or experimental procedure suggested by a digital twin.

VoxJuris

6. Artificial Intelligence and Algorithmic Accountability

Digital twins frequently use artificial intelligence to analyse patient information and simulate possible clinical outcomes.

However, AI-generated predictions can be inaccurate because of:

Incomplete patient information.

Biased training datasets.

Incorrect medical assumptions.

Poor-quality sensor information.

Outdated algorithms.

Inadequate testing.

Unexplained prediction mechanisms.

Major legal issues

Algorithmic transparency: Healthcare providers should understand the limitations of the system they use.

Explainability: Doctors should be able to explain why an algorithm recommends a particular treatment.

Human supervision: Medical decisions should not be delegated blindly to an automated model.

Discrimination: Digital twins should be evaluated for unequal performance across different patient populations.

Accountability: Organisations should establish clear responsibility for system development, validation, deployment and monitoring.

Comparative legal framework: European Union

The European Union provides an important regulatory example through:

Regulation (EU) 2017/745 – Medical Device Regulation.

Regulation (EU) 2016/679 – General Data Protection Regulation.

Regulation (EU) 2024/1689 – Artificial Intelligence Act.

Where a digital twin qualifies as medical-device software, the Medical Device Regulation may apply. Where it incorporates high-risk AI, relevant AI Act obligations may also apply.

These frameworks address matters such as risk management, technical documentation, data quality, transparency and human oversight.

European Commission+2

7. Important Comparative Case Laws

There are few reported decisions directly addressing healthcare digital twins. Nevertheless, established medical-law judgments provide principles that can be applied by analogy.

Montgomery v. Lanarkshire Health Board (2015) is particularly important. The UK Supreme Court held that doctors must take reasonable care to inform patients about material risks and reasonable alternative treatments.

Applied to digital twins, patients should receive understandable information about the limitations, uncertainties and material risks of a digital-twin-assisted treatment when those matters are relevant to their decision.

Bailii+1

8. Intellectual Property Rights in Digital Twins

Digital twins may contain contributions from hospitals, software companies, medical researchers, pharmaceutical manufacturers and patients.

This creates several intellectual-property questions.

A. Copyright

Copyright may protect original software code, databases and certain original digital representations, subject to the applicable law.

B. Patents

Patent protection may be available for qualifying technical inventions. However, abstract ideas, mathematical methods and computer programs as such face statutory limitations, including under Section 3(k) of the Indian Patents Act, 1970.

C. Trade secrets

Companies may protect proprietary simulation techniques, source code and confidential algorithms through appropriate confidentiality and trade-secret arrangements.

D. Patient ownership and control

A patient may have important privacy, consent and data-protection rights over personal health information. These rights should not be confused with automatic ownership of the software or copyright in the digital twin itself.

E. Commercialisation

If a pharmaceutical company uses patient-derived digital twin data to develop a commercial treatment, the parties must examine consent, data-protection compliance, contractual rights and applicable research-ethics requirements.

9. Cybersecurity and Digital Twin Manipulation

A digital twin can become dangerous if an unauthorised person manipulates its underlying data.

For example:

Altering a patient's blood-pressure information.

Changing the simulated dosage response.

Manipulating predicted tumour progression.

Accessing confidential genetic information.

Modifying surgical simulation results.

Injecting false information into a real-time monitoring system.

Such conduct may expose patients to physical harm and create civil, regulatory or criminal liability.

Healthcare institutions should implement:

Strong authentication and access controls.

Encryption of sensitive information.

Audit trails and access monitoring.

Secure data transmission.

Regular software vulnerability assessments.

Backup and recovery systems.

Incident-response procedures.

Independent security testing.

The IT Act, 2000 and applicable data-protection requirements may provide legal remedies and obligations depending on the nature of the incident.

10. Clinical Research and Experimental Digital Twins

Digital twins are increasingly relevant to clinical research because they can simulate disease progression and treatment outcomes without requiring every experiment to be performed directly on a human participant.

However, a digital simulation is not automatically equivalent to a clinically validated human trial.

Important legal concerns include:

Whether patient information was collected lawfully.

Whether research participants provided appropriate consent.

Whether the model has been scientifically validated.

Whether simulated outcomes are being misrepresented as proven clinical results.

Whether digital-twin experiments can replace or reduce conventional clinical trials.

Whether research findings are reproducible and independently verifiable.

In India, the ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017, provide an important ethical framework.

Where digital twins are used in research involving human participants or identifiable patient information, the applicable institutional ethics committee requirements must be considered.

Relevant legal principle: Research involving human biological information must respect participant autonomy, confidentiality, scientific integrity and research ethics.

11. Product Liability and Manufacturer Responsibility

A digital twin may be supplied as part of a medical device, software platform or healthcare service.

If defective software causes physical injury, several legal questions arise:

Was the software properly tested?

Was the manufacturer aware of its limitations?

Were known risks disclosed?

Were software updates properly implemented?

Was the hospital provided with adequate instructions?

Did the defect cause or contribute to the patient's injury?

Under the Indian Consumer Protection Act, 2019, product-liability provisions may become relevant where the statutory requirements are satisfied.

Potential defendants may include manufacturers, product sellers and service providers, depending on their respective roles and the applicable statutory provisions.

12. Digital Personal Data Protection Rules, 2025: Important Development

India's Digital Personal Data Protection Rules, 2025 were notified in November 2025.

An important distinction is that notification and commencement are not the same thing.

The commencement notification establishes a phased implementation timetable:

Therefore, as of 6 November 2026, the principal processing, consent and data-principal-rights provisions have not all commenced. Healthcare organisations must distinguish provisions already in force from those awaiting their scheduled commencement.

This is particularly important for organisations creating patient digital twins, because compliance planning should cover both existing legal obligations and the upcoming DPDP framework.

MeitY+2

13. Major Legal Challenges in Digital Twin Healthcare

14. Proposed Legal Reforms for India

India could strengthen digital twin healthcare governance through the following reforms.

1. Digital Twin Healthcare Certification

Establish a certification framework for digital twins used in high-risk medical applications.

2. Mandatory Patient Disclosure

Require healthcare providers to explain when digital twins materially influence diagnosis or treatment.

3. Algorithmic Audit Requirements

Introduce independent audits of accuracy, bias, reliability and model performance.

4. Clear Liability Allocation

Clarify the respective responsibilities of hospitals, medical practitioners, software developers and manufacturers.

5. Patient Data Governance

Establish clear rules for secondary use, commercialisation, retention and deletion of patient-derived digital models.

6. Cybersecurity Standards

Require minimum security standards for healthcare digital twin platforms.

7. Human Oversight

Ensure that high-risk treatment decisions retain appropriate professional supervision.

8. Clinical Validation

Require appropriate scientific validation before digital twin systems are used for consequential clinical decisions.

15. Important Case Laws: Consolidated Analysis

The following judgments provide the principal legal foundations for analysing digital twin healthcare disputes.

A note on precedent: These are foundational or analogous judgments, not cases specifically deciding liability for healthcare digital twins. Their principles can guide future litigation, but the legal outcome will depend on the technology, facts, applicable legislation and evidence.

16. Hypothetical Judicial Case Study

Consider the following hypothetical dispute.

Case: A Patient v. Digital Twin Healthcare Hospital

A hospital creates a digital twin of a cancer patient. The system predicts that the tumour is unlikely to progress rapidly. The treating doctor relies on this prediction and postpones surgery.

Six months later, the tumour progresses significantly, resulting in serious physical injury.

The patient files a legal claim against the hospital and software manufacturer.

Possible judicial questions

Was the digital twin clinically validated?

Was the patient informed that the treatment decision relied on an AI-generated prediction?

Did the doctor exercise independent professional judgment?

Was the prediction based on accurate and sufficient patient information?

Did the software manufacturer adequately disclose known limitations?

Can the patient establish a causal relationship between the defective prediction and the injury?

Possible legal outcomes

The hospital may face liability if its clinical procedures fell below the applicable standard of care.

The doctor may face professional negligence proceedings if unreasonable reliance on the software is established.

The manufacturer may face product-liability claims if a qualifying defect is established.

Privacy-related proceedings may arise if patient information was unlawfully processed.

The court would need to examine expert medical evidence, software documentation, clinical records and the causal relationship between the alleged breach and injury.

17. Conclusion

Digital Twin Healthcare Law represents an important emerging intersection of medical jurisprudence, artificial intelligence, constitutional law, intellectual property and data protection.

Digital twins offer significant opportunities for personalised treatment, predictive diagnosis, surgical planning and pharmaceutical research. However, their use also raises serious concerns about patient autonomy, privacy, algorithmic accuracy, cybersecurity and professional accountability.

In India, the constitutional principles established in Puttaswamy, the informed-consent doctrine in Samira Kohli, and the medical-negligence principles in Jacob Mathew provide important foundations for addressing these issues.

The central legal principle should be that digital healthcare innovation must not undermine patient dignity, informed consent, medical safety or the right to privacy.

A comprehensive regulatory framework specifically addressing digital twin healthcare would help establish clear responsibilities, protect patients and encourage scientifically reliable medical innovation.

18. Important Research References

For further legal research, consult:

India Code – Indian legislation.

Supreme Court of India – Judicial decisions.

Ministry of Electronics and Information Technology – DPDP legislation and rules.

Indian Council of Medical Research – Biomedical research ethics.

European Commission – Health – European medical-device regulation.

World Health Organization – Digital health governance.

Research significance: Digital Twin Healthcare Law can be developed as a distinct research subject covering medical negligence, digital consent, patient-data ownership, AI liability, clinical validation, digital experimentation and constitutional protection of health information.